XML 71 R52.htm IDEA: XBRL DOCUMENT v3.22.1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of Share-Based Compensation Expenses

Share-based compensation expenses recognized during the years presented are as follows:

 

 

 

Year ended December 31,

 

 

2019

 

2020

 

2021

 

 

RMB

 

RMB

 

RMB

Share-based compensation expenses

 

 

 

 

 

 

- Share-based compensation of founders' restricted shares (a)

 

50,837

 

1,030,178

 

-

- Related to repurchase of founders’ ordinary shares (b)

 

24,158

 

146,294

 

-

- Related to the issuances of preferred shares to investors (c)

 

-

 

303,627

 

-

- Related to redesignation of founder’s ordinary shares to preferred shares (Note 18(b))

 

-

 

1,852

 

-

- Related to accelerated vesting of share options (d)

 

 

 

138,729

 

66,429

- Related to vesting of share options (f)

 

-

 

279,908

 

464,011

Total

 

74,995

 

1,900,588

 

530,440

 

Movement in Number of Share Options Granted and Related Weighted Average Exercise Prices

Movements in the number of share options granted and their related weighted average exercise prices are as follows:

 

 

 

Number of

options

 

Weighted

average

exercise

price (US$)

 

Weighted

average

remaining

contractual life

(years)

 

Aggregate

intrinsic

value

(US$’000)

As of January 1, 2019

 

67,404,501

 

0.0065

 

5.04

 

 

Granted

 

62,896,041

 

0.0080

 

 

 

 

Forfeited

 

(3,414,045)

 

0.0065

 

 

 

 

Modified from options to restricted shares

 

(58,297,400)

 

0.0073

 

 

 

 

 

 

 

 

 

 

 

 

 

As of December 31, 2019

 

68,589,097

 

0.0073

 

4.58

 

 

Granted

 

136,230,857

 

0.2960

 

 

 

 

Cancelled

 

(1,849,265)

 

0.0006

 

 

 

 

Forfeited

 

(1,544,428)

 

0.2062

 

 

 

 

Accelerated vesting and exercised

 

(15,518,385)

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

As of December 31, 2020

 

185,907,876

 

0.2179

 

13.73

 

 

Granted

 

55,388,338

 

0.8790

 

 

 

 

Forfeited

 

(4,570,510)

 

0.8782

 

 

 

 

Exercised

 

(7,686,832)

 

0.0392

 

 

 

 

 

 

 

 

 

 

 

 

 

As of December 31, 2021

 

229,038,872

 

0.3706

 

12.98

 

38,230

 

 

 

 

 

 

 

 

 

Exercisable as of December 31, 2021

 

52,682,699

 

 

 

 

 

23,460

Schedule of Key Assumptions Used to Determine Fair Value of Share Options

The Company has used binomial option-pricing model to determine the fair value of the share options as of the grant dates. Key assumptions are set as below:

19.

SHARE-BASED COMPENSATION (Continued)

(f) Vesting of share options (Continued)

 

 

 

Year ended December 31,

 

 

2019

 

2020

 

2021

 

 

RMB

 

RMB

 

RMB

 

 

 

 

 

 

 

Weighted average fair value per option granted

 

1.0360

 

7.3798

 

1.3882

Weighted average exercise price

 

0.0554

 

2.0418

 

5.6699

Risk-free interest rate (1)

 

1.9%~2.8%

 

0.48%~1.01%

 

1.45%-1.97%

Expected term (in year) (2)

 

4~7

 

10~16

 

14

Expected volatility (3)

 

45.0%~48.0%

 

50.9%~55.9%

 

54.69%-57.00%

Dividend yield (4)

 

0%

 

0%

 

0%

 

 

(1)

The risk-free interest rates of periods within the contractual life of the share option are based on the daily treasury long-term rate of U.S. Department of the Treasury as of the valuation dates.

 

(2)

The expected term is the contract life of the option.

 

(3)

Expected volatility is estimated based on the average of historical volatilities of the comparable companies in the same industry as at the valuation dates.

 

(4)

The Company has no history or expectation of paying dividend on its ordinary shares. The expected dividend yield was estimated based on the Company’s expected dividend policy over the expected term of the option.

Schedule of Share-Based Compensation Expenses included in Statement of Operations

For the years ended December 31, 2019, 2020 and 2021, share-based compensation expenses have been included in the following accounts in the consolidated statement of operations:

 

 

 

Year ended December 31,

 

 

2019

 

2020

 

2021

 

 

RMB

 

RMB

 

RMB

 

 

 

 

 

 

 

Fulfilment expenses

 

-

 

2,947

 

13,122

Selling and marketing expenses

 

-

 

54,332

 

80,558

General and administrative expenses

 

74,995

 

1,841,409

 

418,823

Research and development expenses

 

-

 

1,900

 

17,937